This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer .

Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payload antibody drug conjugates ...

Madras High Court Directs Reconsideration. Legal News and Analysis - India - Intellectual Property - Conventus Law ...

Files Provisional Patent To Strengthen Protection Of AVERSA(TM) Abuse-Deterrent Technology. Nutriband (NASDAQ: NTRB) , a developer of prescription transdermal pharmaceutical products, announced the ...

The technology uses high temperatures and resin systems to recover metal concentrates from semiconductor acid waste.

Nutriband files provisional patent application to enhance its AVERSA™ transdermal abuse deterrent technology being developed for patches containing opioids and stimulants with a potential for abuse.

The Federal Circuit held that provisional application language omitted from the final patent cannot support broader claim ...

The U.S. Court of Appeals for the Federal Circuit (CAFC) on Monday issued a decision vacating a United States District Court ...

Researchers have developed a new class of nontoxic, biodegradable solid lubricants that can be used to facilitate seed ...

As Kennesaw State University strives to conduct research with relevant societal impact, it remains essential to provide ...

For startups, patents are often the first line of defense in building a competitive moat. They signal to investors that your ...

Researchers in McGill's Department of Physics have developed a new device that can trap and study DNA molecules without touching or damaging them. The device, which uses carefully tuned electric ...